1. COVID-19 {#sec1}
===========

A novel corona virus (nCoV) identified as pathogen and cause some illness which leads to death cause of massive alveolar injure and progressive respiratory stoppage \[[@bib1]\]. From the time when 2019 month of December, the novel corona virus disease (COVID-19) has turn out to be a major pandemic threat in china and moreover the world \[[@bib2]\]. It is named as 2019-nCoV by means of World health organization (WHO) formally. 2019-nCoV recognized as etiological representative of the disease and phylogenetic testing of the virus was differs from formerly acknowledged corona viruses \[[@bib3]\]. Recently, information regarding the epidemiology and medical features of pneumonia originated with 2019-nCoV is very scanty. The patients of 2019-nCoV pneumonia was confirmed and admitted headed for Jinyintan hospital, Wuhan; first patient with 2019-nCoV to be reported resting on \[[@bib4]\]. (see [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"} , [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"} )Table 1At the time of preparing this manuscript as on may 25, 2020 a tabular data accurate with following information of affected people with COVID-19.Table 1S. NoCountryAffectedDeathRecovered1.United states1,689,61899,381451,7452.Spain282,85228,752196,9583.Italy229,85832,785140,4794.France182,58428,36764,6175.India141,228405758,7276.Iran137,7247451107,7137.China82,985463478,2688.Singapore31,9602314,8769.Southkorea11,20626710,22610.Thailand3042572928Table 2List of south Indian medicinal plants inhibits several types of viruses.Table 2Indian Medicinal plants (South)VirusEffectivenessReference*Azadirachta indica*Dengue virusLeaf extract (Aqueous) inhibits DEN-2 *in vivo*Parida et al., 2002 \[[@bib42]\]*Hippophae rhamnoides*Dengue virusLeaf extract has significant anti-dengue activityMonika et al., 2008 \[[@bib43]\]*Andrographis paniculata*\
Nilavembu kudineer (NVK)Dengue virus\
Chikungunya virus (CHIKV)NVK provides protection against DENV and CHIKVJain et al., 2019 \[[@bib44]\]*Glycine* max (black)Human adenovirus (type 1)Inhibits human ADV-1 in dose dependant mannerYamai et al., 2003 \[[@bib45]\]*Ficus religiosa*Human rhino virus (HRV) & Respiratory syncytial virus (RSV)Bark extract endowed with antivirus activity against HRV & RSVCagno et al., 2015 \[[@bib46]\]*Sesbania grandiflora*Herpes simplex virusExtract possess strong antiviral against HSVArthanari et al., 2012 \[[@bib47]\]*Carissa edulis*Herpes simplex virusExhibits anti HSV-1&2 *invitro* and *in vivo* stronglyTolo et al., 2006 \[[@bib48]\]*Achyranthus aspera*Herpes simplex virusInhibits earlier stages of HSV multiplicationsMukerjee et al., 2013 \[[@bib49]\]*Guazuma ulmifolia Lam*Polio virusExtracts inhibits polio replicationsDeFelipe et al., 2006 \[[@bib50]\]*Punica granatum* LHuman herpes virus-3Phytochemical extract exhibits potential anti viral activityAngamuthu et al., 2019 \[[@bib51]\]*Phyllanthus amarus*Human immuno deficiency virusInhibits HIV replicationNotka et al., 2004 \[[@bib52]\]Hepatitis B virusPlant extract had lost HBV antigen surfaceThyagarajan et al., 1988 \[[@bib53]\]*Avicennia marina*Hepatitis B virusInhibits HBV antigenBeula et al., 2012 \[[@bib54]\]*Terminalia bellerica*HIV-1\
Pseudo virusesPlant extract against HIV-1Jayasundar et al., 2019 \[[@bib55]\]*Canthium coromandelicum*HIVLeaf extract control HIV infectionsChinnaiyan et al., 2013 \[[@bib56]\]*Moringa oleifera*HIVLeaves used to inhibit viral replicationEze et al., 2014 \[[@bib57]\]Epstein bar virus (EBV)Leaves and seeds inhibits activity against EBV activationMurakami et al., 1998 \[[@bib58]\]Fig. 1Model structure of the nCoV.Fig. 1Fig. 2Illustrative representation of the nCoV symptoms.Fig. 2Fig. 3Prevention measures to stop spreading nCoV.Fig. 3

Corona virus is able to the source of multiple system infection in the range of animals and severe respiratory tract infections among humans including severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). On the root of phylogenetic analysis linked with corona viruses the International committee on virus taxonomy published a script on bioRxiv. Jiang et al. \[[@bib5]\], suggested an assigned 2019-nCoV severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) like WHO renamed a disease of corona virus (COVID-19). The Middle East respiratory syndrome is originated with 2019-nCoV (MERS-CoV), which has been isolated at first in the Saudi in 2012 from respiratory tract discharge, a person who died from as of viral pneumonia \[[@bib6]\]. COVID-19 that cause respiratory, enteric and central nervous system in many species as in humans too. These are noted as enveloped, positive stranded RNA viruses with a genus of Coronaviridae family. These genomic RNA is 27--32 kb in size and polyadenylated \[[@bib7]\].

2. Epidemic outbreak {#sec2}
====================

The nCoV belongs to the linkage B of genus Beta *coronavirus* which is phylogenetically related with close enough to bat SARS- alike coronaviruses \[[@bib8]\]. In history, nCoV is one another exceedingly pathogenic coronavirus enroute for human. The virus has its own high transmission ability as well as towering mobility and transience and so it has lift up world apprehension \[[@bib9]\]. Hence, it is very hard in management for public health care and physician in this outbreak. Earlier categorization of patients is an essential way to take control measures of these pandemics while urgent situation management has to be accomplishing in some outbreaks as like SARS and 2019-nCoV \[[@bib10]\]. Hospital based outbreaks are notorious to involving human to human transmission of spread can be arrested by some of the control measures \[[@bib11]\]. China has determined on habitual public health outburst with; quarantine, isolation and social hostility \[[@bib12]\]. Likewise the current outbreak of nCoV gives many provinces of china in concern China medicine (CM) with managing and preventing events are mainly to know about Oral Chinese herbal medicine formulae. This is in need to provide regulation for the prevention of the virus outbreak \[[@bib13]\]. At present, the decisive effect of this outbreak is indistinct as it growing rapidly. For this problematic condition, it can be clear with prevention steps are much important to take by public, before the eruption must be defeated; yet another viral pathogen emerging in role with challenge to human.

3. Sign and clinical outcomes {#sec3}
=============================

3.1. Symptoms {#sec3.1}
-------------

For nCoV the symptoms of infection become visible approximately after an incubation period of 5.2 days \[[@bib14]\]. The inceptions of nCoV with most common symptoms are cough, fever, headache, sore throat, diarrhoea, rhinorrhoea, sneezing, hypoxemia \[[@bib9],[@bib15], [@bib16], [@bib17]\]\] and recently bland diet.

3.2. Diagnosis {#sec3.2}
--------------

First the majority of 41 patients confirmed with diagnosis of lower respiratory tract sample to detect the RNA viral detection. Adding up with nucleic acid tests as the diagnosis (Collection of blood, nasal and throat swabs) of COVID-19 pneumonia; it undergoes several clinical examinations such as chest CT, blood counts, medical history of the affected person and exposure to the specific symptoms \[[@bib18]\]. In addition Remdesivir (RDV), this could inhibit corona infection *invitro*. RDV is a novel nucleotide analogue proved to be an effective Pan-CoV \[[@bib19],[@bib20]\] antiviral. Recently, a phase 3 clinical trial of secure and protective effect of RDV is ongoing in Wuhan \[[@bib21]\]. Real time reverse transcriptase (RT-PCR) detection is advantages as specific detecting methods of corona virus, which has been diagnosed as helpful in the way of early infections \[[@bib22]\]. This assay is still leading method to be applied for detecting corona virus (All type) \[[@bib23],[@bib24]\]. The broad spectrum of an antiviral medicine such as nucleoside analogues and HIV protease inhibitors could attenuated these infectious virus in anticipation of specific antiviral befall accessible \[[@bib25]\]. Further, the clinical agent EIDD-2801 has high therapeutic efficiency against pandemic viral infection as it to be considered for the treatment of COVID-19 \[[@bib26]\]. Preclinical basis effectiveness of chloroquine for to treat COVID-19, it is safety from long term usage medical proven customs \[[@bib27]\]. According to Cortegiani et al. \[[@bib28]\], high quality clinical trials from various locations are needed in emergency worldwide for COVID-19.

4. Prevention recommends for 2019-nCoV {#sec4}
======================================

WHO is subjecting counsel on preventing the spread of COVID-19 \[[@bib29]\]. They advise to avoid travel at highly risk areas as well as to prevent the entry of the people who are from closely affected region, consuming meat from known nCoV affected province and contact with symptomatic individuals \[[@bib30]\]. Personal hygiene can be determining the self as well as society health. Cleaning hands with soap than using sanitizer can reduce the risk of viruses on hand and washed out when it\'s used frequently as specific after using bathroom, coughing and sneezing \[[@bib31]\]. Using of face masks is also important to prevent the entry of pathogen via respiratory system \[[@bib32]\]. For huge community social distancing could be maintained to reduce the interaction of the public \[[@bib33]\]. Symptom checker is used for the preventive channel for the 2019-nCoV outbreak \[[@bib34]\].

5. Natural medicine to control virus {#sec5}
====================================

5.1. South Indian medicine for the control of virus {#sec5.1}
---------------------------------------------------

Spread of infection while epidemic can be controlled with persuasive antiviral herbal interference. India has prosperous and unique collection of plants an estimated 45,000 species of plants have been used in traditional medicine systems \[[@bib35]\]. Tamilnadu is one of the mainly botanized zones of south India. The medicinal properties of plants were analyzed with various types of researchers in Tamilnadu. It is for the documentation and provides wide information concerning the medicinal plant from traditional healers to protect the fact of plant usage \[[@bib36]\]. Traditional plants used in India in relation to 4000 years getting on. Herbal plants have been used by all cultures throughout history. A mainstream of global population in developing and squat earning countries relies for primary health care using traditional medicine \[[@bib37]\]. An extensive assortment of pharmaceutical attention has been expressed in plants widely. Plant based vaccines are being evaluated in clinical trials for influenza, hepatitis B etc., \[[@bib38]\]. People have been used medicinal plants to cure severe disease habitually and also Indian medicinal plants have been examined for antiviral properties \[[@bib39]\]. Only some reported on plants from Tamilnadu in spite of the plants used by many tribal people throughout for the management of viral infections \[[@bib40]\]. More than 85% of individuals in developing countries use these medicines for health concern \[[@bib41]\]. It is stressed necessitate for further investigation and incorporation towards modern plant based medicines.

6. Conclusion {#sec6}
=============

The impression of plant based medicine constitutes an applicable way for the expansion of vaccines with attractive features. Seeing as noteworthy add up to plant extracts have capitulate positive outcomes it seems reasonable potential antiviral agents so far reported. The pharmacological characteristic of major south Indian medicinal plants further needs to investigate the exploration of producing vaccines to treat several viral diseases. It is very important these plant based concern not only focused on vaccines and medicines but also the plant based coated clinical equipments like masks, soap and sanitizers etc., As the review concluded the plant based sources has may have the ability to kill the viral based diseases so far, hence it is proven that variety of plant compounds yet to be examined for future invention for the control of COVID-19 like deadly diseases. The unknown fact and formulae about the effectiveness of some plants may be there, therefore medicinal plant and its compound may have the ability to fight against 19-nCoV.
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